Pricing Log in Create free account

Evaxion A/S - Sponsored ADR (EVAX) vs NextCure, Inc. (NXTC)

Evaxion A/S - Sponsored ADR and NextCure, Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR and NextCure, Inc. are of similar size ($23.4M and $23.0M). Across the 13 metrics below, Evaxion A/S - Sponsored ADR leads on 7 and NextCure, Inc. on 6.

Valuation

Metric EVAX NXTC Biotechnology median
P/E n/m n/m 10.60
P/S 2.06 1.03 9.40
P/B 2.31 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.38 0.39 9.02
Earnings yield (32.88%) (193.55%) (32.88%)
Free cash flow yield (139.47%) (133.11%) (23.13%)

Profitability

Metric EVAX NXTC Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (96.10%) (195.22%) (51.96%)
Return on assets (36.20%) (121.60%) (46.06%)
Return on invested capital (245.79%) 0.00% 0.00%

Growth

Metric EVAX NXTC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 87.79% 17.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVAX NXTC Biotechnology median
Debt to equity 0.71 0.00 0.00
Current ratio 5.06 3.47 4.97
Net debt to EBITDA 1.87 0.75 1.01

Dividend

Metric EVAX NXTC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EVAX NXTC Biotechnology median
Market cap 23.02m 23.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack